GLP-1 receptor is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-03-16. Numbers and descriptions here follow the published literature rather than marketing material.
The peptide backbone is chemically modified to resist rapid enzymatic breakdown in the body. A fatty acid side chain promotes binding to serum albumin, which slows renal clearance and supports an extended circulation time. These modifications allow less frequent administration than would be possible with an unmodified peptide. The precise contribution of glucagon receptor activation to the overall metabolic effect remains an area of active investigation, because glucagon raises glucose while also increasing energy expenditure.
Development has progressed through early- and mid-stage human studies in adults with obesity and with type 2 diabetes. Published phase 2 data reported reductions in body weight and improvements in glycemic markers over the treatment period. No regulatory agency has approved the compound for any indication, and it remains available only within controlled research settings. Whether benefits observed in trials translate into durable outcomes after treatment stops is not yet established.
Retatrutide is an investigational synthetic peptide that acts as an agonist at three distinct G protein-coupled receptors. It combines activity at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor within a single molecule. This multi-receptor profile distinguishes it from earlier incretin-based compounds that engage one or two of these pathways. Researchers designed the molecule to test whether simultaneous activation produces greater metabolic effects than single or dual agonism alone.
Several questions about the compound remain unresolved. The durability of weight reduction after treatment stops, the frequency of gastrointestinal side effects, and the long-term cardiovascular profile are topics of ongoing study. Regulatory submissions and phase 3 trial outcomes have not been fully reported in the public literature. Because most available data come from controlled trials rather than general-population use, conclusions about effectiveness outside study settings are provisional. The distinction between established findings and open questions matters when interpreting early coverage of the drug.
Retatrutide is an investigational peptide developed by a pharmaceutical company as a multi-receptor agonist for treating obesity and type 2 diabetes. The compound emerged from research into gut-hormone analogues that act on several receptors simultaneously rather than on a single target. Early preclinical work examined how combined activity at three distinct receptors might produce greater metabolic effects than single-receptor compounds. Published phase 2 results have described substantial reductions in body weight among participants, although the compound remains unapproved in most jurisdictions as of the mid-2020s.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Not a small molecule |
| Receptor targets | GLP-1, GIP, glucagon | Triple agonist activity |
| Appearance | White to off-white powder | Lyophilized solid |
| Solubility | Soluble in water | Also in aqueous buffers |
| Storage | −20 °C or below | Protect from light and moisture |
开发进程从早期单次和多次给药研究推进至大规模后期试验。公开报告显示，参与者在体重和相关代谢指标上出现变化，但完整数据需经同行评审并接受独立复核。试验设计通常包括随机、双盲和对照设置，以区分药物效应与行为干预。监管提交和标签范围尚未确定；长期维持效果与心血管结局仍是开放问题。
与仅靶向单一受体的同类药物相比，瑞他鲁肽增加胰高血糖素受体成分，理论上可提高能量消耗并改变脂肪分布。临床中观察到的体重变化是否主要来自该额外机制，目前尚无定论。胃肠道反应是该类药物常见不良事件，试验中通过剂量递增和监测进行管理。停药后体重反弹、个体差异和长期耐受性仍需更多数据。
Retatrutide is a synthetic peptide developed as a single molecule that activates three distinct hormone receptors: GLP-1, GIP, and glucagon. The compound carries the internal designation LY3437943 and was engineered by modifying the backbone of glucose-dependent insulinotropic polypeptide. Its sequence incorporates non-natural amino acids and a fatty acid side chain that extends circulation time. The triple-agonist design aims to combine appetite suppression, improved insulin response, and increased energy expenditure in one agent. Published reports describe it as an investigational product rather than an approved medicine.
Each receptor contributes a different physiological effect. Activation of the GLP-1 receptor slows gastric emptying and reduces appetite signaling in the brain. GIP receptor activity influences insulin secretion and lipid handling, while glucagon receptor stimulation raises energy use and fat oxidation. Combining these pathways is intended to produce weight loss beyond what single- or dual-receptor agonists achieve. Researchers attribute the observed potency to simultaneous engagement of all three targets, though the exact contribution of each receptor to overall effect remains under investigation.
供应环节涉及来源核实与文件审核两类工作。分析证书、批次记录以及第三方检测报告构成常见的可追溯材料。来源不清的样品很难确认身份与纯度，因此核实步骤在实际操作中具有明确意义。缺少方法细节的报告通常无法复核。
多肽类化合物的表征通常依赖色谱与质谱联用技术。反相高效液相色谱用于评估纯度与有关物质，质谱用于确认分子量，肽图分析通过酶解碎片比对验证一级结构。这些手段组合使用，可以把目标产物与降解产物或类似物区分开来。单一方法往往不足以完成完整确认。
稳定性研究一般关注脱酰胺、氧化与聚集三类降解路径。脱酰胺多发生在天冬酰胺残基上，氧化常涉及甲硫氨酸与色氨酸，聚集则与浓度、温度以及容器界面接触有关。强制降解实验用于识别分子中较敏感的位点。这些结果会直接影响储存条件的设定与有效期的判断。
Retatrutide is an investigational synthetic peptide that acts on three receptor targets at once: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon. It is developed by Eli Lilly and appears in the literature and in trial registries under the code LY3437943. The molecule belongs to a class of engineered peptides designed to resist rapid breakdown and permit infrequent subcutaneous administration. No regulatory agency has approved it for clinical use, and all available human data come from controlled trials rather than from routine practice.
The intended pharmacology combines three signals in one molecule. GLP-1 receptor activation reduces appetite and slows gastric emptying, effects already exploited by approved incretin-based therapies. GIP receptor engagement is associated with improved insulin sensitivity and with direct effects on adipose tissue, although how much it contributes to overall outcomes is still debated. Glucagon receptor agonism raises energy expenditure and supports hepatic lipid handling, a mechanism that also tends to increase glucose output. The triple profile is hypothesized to produce a larger metabolic effect than single or dual agonism, but the relative weight of each receptor in humans is not settled.
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
=== Cephalopod alien origin === In 2018, Wickramasinghe and over 30 other authors published a paper in Progress in Biophysics and Molecular Biology entitled "Cause of Cambrian Explosion - Terrestrial or Cosmic?" which argued in favour of panspermia as the origin of the Cambrian explosion, and posited that cephalopods are alien lifeforms that originated from frozen eggs that were transported to earth via meteor. The claims gained widespread press coverage. Virologist Karin Mölling, in a companion commentary published in the same journal, stated that the claims "cannot be taken seriously".
Besides inhibiting human acetylcholinesterase (although to a lesser degree than the insect enzyme), carbamate insecticides also target human melatonin receptors. The human health effects of carbamates are well documented in the list of known endocrine disruptor compounds. Clinical effects of carbamate exposure can vary from slightly toxic to highly toxic depending on a variety of factors including such as dose and route of exposure with ingestion and inhalation resulting in the most rapid clinical effects. These clinical manifestations of carbamate intoxication are muscarinic signs, nicotinic signs, and in rare cases central nervous system signs.
=== Multidisciplinary doctoral programme === Has been instituted for students who have completed masters in any relevant discipline of natural sciences, medicine, engineering and other related sciences. RCB recruits Junior Research Fellowships (JRFs) twice during an academic year and already mentors 31 Research Fellows.
=== Second allegation of domestic abuse === About six months after the ATP declined to take action against Zverev, in July 2023, allegations from a second woman became public through a court filing. The public prosecution office requested a penalty order against Zverev in a Berlin criminal court over alleged bodily harm against Brenda Patea, Zverev's ex-girlfriend and the mother of his daughter. On 2 October 2023, the court issued a summary penalty order against Zverev, which included a fine of €450,000. In Germany, summary orders can be issued, typically without a prior hearing, when a judge considers the evidence sufficient to support the accusation and a trial is not deemed necessary. Zverev lodged an objection against the order, which under German law resulted in a public trial. Patea spoke publicly for the first time about the alleged abuse on 1 November 2023 in an interview with the Süddeutsche Zeitung. She said that during a dispute in May 2020, Zverev pushed her into a wall and choked her. In January 2024, Zverev was appointed to serve on the ATP Players Advisory Council. The ATP has been criticized for allowing him to serve on the council while the domestic abuse charge is pending in a criminal court. Also in January 2024, Zverev was featured on the second season of the Netflix series Break Point in an episode focused on his comeback from injury. Netflix was criticized for ignoring both allegations of domestic abuse. One columnist argued that "Break Point promised to take viewers behind the curtain of professional tennis and reveal the personalities behind it.
In the initial phase of Germany's invasion of the Soviet Union, Cossack émigrés were initially barred from political activity or travelling into the occupied Eastern territories. Hitler had no intention of entertaining the political aspirations of the Cossacks, or any minority group, in the USSR. As a result, collaboration between Cossacks and the Wehrmacht began in ad hoc manner through localized agreements between German field commanders and Cossack defectors from the Red Army. Hitler did not officially sanction the recruitment of Cossacks and lift the restrictions imposed on émigrés until the second year of the Nazi-Soviet conflict. During their brief occupation of the North Caucasus region, the Germans actively recruited Cossacks into detachments and local self-defense militias. The Germans even experimented with a self-governing district of Cossack communities in the Kuban region. When the Wehrmacht withdrew from the North Caucasus region in early 1943, tens of thousands of Cossacks retreated with them, either out of conviction or to avoid Soviet reprisals. In 1943, the Germans formed the 1st Cossack Cavalry Division, under the command of General Helmuth von Pannwitz. While its ranks mostly comprised deserters from the Red Army, many of its officers and NCOs were Cossack émigrés who had received training at one of the cadet schools established by the White Army in Yugoslavia. The division was deployed to occupied Croatia to fight Tito's Partisans. There, its performance was generally effective, although at times brutal.
Sources: en.wikipedia.org
=== Mechanism of action === The important interaction between phosphate and magnesium ions makes magnesium essential to the basic nucleic acid chemistry of all cells of all known living organisms. More than 300 enzymes require magnesium ions for their catalytic action, including all enzymes using or synthesizing ATP and those that use other nucleotides to synthesize DNA and RNA. The ATP molecule is normally found in a chelate with a magnesium ion.
== Synopsis == In a remote village in Epirus, a woman murders her husband, who had just returned from Germany, where he had gone to work, with the help of her lover. The crime is never shown on screen. The main characters (judge, policemen, journalists) try to reconstruct and understand a news item that escapes them.
Saffron was a notable ingredient in certain Roman recipes such as jusselle and conditum. Such was the Romans' love of saffron that Roman colonists took it with them when they settled in southern Gaul, where it was extensively cultivated until Rome's fall. With this fall, European saffron cultivation plummeted. Competing theories state that saffron only returned to France with 8th-century AD Moors or with the Avignon papacy in the 14th century AD. Similarly, the spread of Islamic civilisation may have helped reintroduce the crop to Spain and Italy. The 14th-century Black Death caused demand for saffron-based medicaments to peak, and Europe imported large quantities of threads via Venetian and Genoan ships from southern and Mediterranean lands such as Rhodes. The theft of one such shipment by noblemen sparked the fourteen-week-long Saffron War. The conflict and resulting fear of rampant saffron piracy spurred corm cultivation in Basel; it thereby grew prosperous. The crop then spread to Nuremberg, where endemic and insalubrious adulteration brought on the Safranschou code—whereby culprits were variously fined, imprisoned, and executed. Meanwhile, cultivation continued in southern France, Italy, and Spain. Direct archaeological evidence of mediaeval saffron consumption in Scandinavia comes from the wreck of the royal Danish-Norwegian flagship, Gribshunden. The ship sank in 1495 while on a diplomatic mission to Sweden. Excavations in 2021 revealed concentrations of saffron threads and small "pucks" of compressed saffron powder, along with fresh ginger, cloves, and pepper.
== Defunct == Beefsteak Charlie's Bikinis Sports Bar & Grill Bill Knapp's Bugaboo Creek Steakhouse Burger Chef Camille's Sidewalk Cafe Carrows Restaurants Cheeseburger in Paradise Chi Chi's Chicken in the Rough Druther's ESPN Zone Fresh Choice Furr's Good Earth Hamburger Hamlet Henry's Hamburgers Horne's Hot 'n Now K&W Cafeterias Koo Koo Roo Lone Star Steakhouse & Saloon Lyon's Morrison's Cafeteria Naugles On the Border Mexican Grill & Cantina Pizza Fusion Royal Castle Red Barn Sambo's ShopHouse Southeast Asian Kitchen Smokey Bones ShowBiz Pizza Place Steak and Ale Sweet Tomatoes/Souplantation Trump Burger Yogi Bear's Honey Fried Chicken York Steak House Zoës Kitchen
Sources: en.wikipedia.org
Retatrutide is an investigational synthetic peptide that activates three metabolic receptors: GLP-1, GIP, and glucagon. It is being studied for obesity and type 2 diabetes. It has not been approved for clinical use.
Earlier incretin therapies engage one or two receptors. Retatrutide adds glucagon receptor activity, which may raise energy expenditure. Whether this produces larger clinical benefits is still being tested.
It has completed phase 2 trials and moved into later-stage evaluation. No regulator has granted approval. Access outside research settings is not authorized.
It is designed as a triple agonist acting on the GLP-1, GIP, and glucagon receptors. This combination is intended to influence appetite, insulin secretion, and energy expenditure. Single-receptor and dual-receptor compounds act on a narrower set of targets.